Genomic Health, Inc.
(NASDAQ : GHDX)

( )
GHDX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
NVTAInvitae Corp. -2.00%32.802.0%$161.38m
AMEDAmedisys, Inc. -4.12%199.2211.5%$120.21m
DVADaVita, Inc. -2.09%79.493.2%$80.24m
GHGuardant Health, Inc. -5.74%80.320.0%$78.78m
ONEM1Life Healthcare, Inc. -8.51%38.060.0%$64.01m
CHEChemed Corp. -2.46%461.8210.1%$58.36m
LHCGLHC Group, Inc. -3.89%174.262.9%$48.77m
NEONeoGenomics, Inc. -2.41%34.996.2%$40.38m
SDCSmileDirectClub, Inc. 7.32%8.870.0%$39.74m
NTRANatera, Inc. -2.20%45.891.3%$37.90m
BIOCBiocept, Inc. -0.50%0.703.0%$27.15m
MDMEDNAX, Inc. 3.68%18.3011.1%$25.66m
GTHGenetron Holdings Ltd. 1.96%14.050.0%$22.21m
ACHCAcadia Healthcare Co., Inc. -0.81%25.2127.1%$17.64m
CSTLCastle Biosciences, Inc. -0.60%41.500.0%$14.58m

Company Profile

Genomic Health, Inc. (NASDAQ: GHDX) is a provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The company is applying its world-class scientific and commercial expertise and infrastructure to lead the translation of massive amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey, from diagnosis to treatment selection and monitoring. The company is based in Redwood City, California, with European headquarters in Geneva, Switzerland.